Evaluation of electrochemiluminescent technology for inhibitors of granulocyte colony-stimulating factor receptor binding
{{output}}
An electrochemiluminescent (ECL) assay was developed to identify compounds that inhibit the interaction of granulocyte colony-stimulating factor (GCSF) with its recombinant human receptor. The ECL technology uses a tris-(bipyridine) chelate of ruthenium, which... ...
